I. Schedel

1.8k total citations
50 papers, 1.1k citations indexed

About

I. Schedel is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, I. Schedel has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 13 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Hematology. Recurrent topics in I. Schedel's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Multiple Myeloma Research and Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). I. Schedel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Multiple Myeloma Research and Treatments (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). I. Schedel collaborates with scholars based in Germany, United States and United Kingdom. I. Schedel's co-authors include H. Deicher, D. Peest, H. Kühnle, S Niesert, Ulrike Bode, Michael Glaubitz, Karl Ulrich Petry, Heinrich G. Köchel, Hans‐Joachim Schmoll and E. Kupsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PEDIATRICS.

In The Last Decade

I. Schedel

49 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Schedel Germany 17 460 358 226 217 207 50 1.1k
Rana Domiati‐Saad United States 20 584 1.3× 263 0.7× 252 1.1× 208 1.0× 227 1.1× 27 1.6k
A. Graham Bird United Kingdom 19 718 1.6× 282 0.8× 251 1.1× 213 1.0× 255 1.2× 31 1.5k
Lars B. Olding Sweden 20 755 1.6× 502 1.4× 92 0.4× 156 0.7× 183 0.9× 52 1.5k
John K. Whisnant United States 19 481 1.0× 709 2.0× 148 0.7× 219 1.0× 265 1.3× 41 1.6k
T.A. Out Netherlands 24 640 1.4× 319 0.9× 335 1.5× 311 1.4× 114 0.6× 62 1.7k
D Baume France 18 337 0.7× 172 0.5× 92 0.4× 172 0.8× 340 1.6× 44 1.0k
Andreas Morell Switzerland 16 442 1.0× 244 0.7× 370 1.6× 268 1.2× 66 0.3× 39 1.2k
Bjarte G. Solheim Norway 28 910 2.0× 227 0.6× 249 1.1× 351 1.6× 253 1.2× 80 2.2k
Russell H. Tomar United States 17 542 1.2× 137 0.4× 231 1.0× 193 0.9× 95 0.5× 56 1.2k
S. S. Crago United States 17 500 1.1× 108 0.3× 253 1.1× 283 1.3× 87 0.4× 34 1.2k

Countries citing papers authored by I. Schedel

Since Specialization
Citations

This map shows the geographic impact of I. Schedel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Schedel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Schedel more than expected).

Fields of papers citing papers by I. Schedel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Schedel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Schedel. The network helps show where I. Schedel may publish in the future.

Co-authorship network of co-authors of I. Schedel

This figure shows the co-authorship network connecting the top 25 collaborators of I. Schedel. A scholar is included among the top collaborators of I. Schedel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Schedel. I. Schedel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Mohammadi, Bahram, I. Schedel, Karolin Graf, et al.. (2008). Role of endotoxin in the pathogenesis of critical illness polyneuropathy. Journal of Neurology. 255(2). 265–272. 14 indexed citations
4.
Schedel, I.. (2004). Posttravel fever attack.. Der Internist. 45(6). 641–654. 1 indexed citations
5.
Wedemeyer, Heiner, Jens G. Kuipers, Konrad L. Streetz, et al.. (2003). A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.. Digestive Diseases and Sciences. 48(7). 1385–1391. 2 indexed citations
6.
Göke, Michael, Axel Leppert, P. Flemming, et al.. (2001). Darmtuberkulose: leichter zu übersehen als zu sichern. Zeitschrift für Gastroenterologie. 39(12). 1015–1022. 3 indexed citations
7.
Schedel, I.. (1999). Phase II study of anti-CD4 idiotype vaccination in HIV positive volunteers. Vaccine. 17(15-16). 1837–1845. 12 indexed citations
8.
Pape, Hans‐Christoph, D. Remmers, M. Grotz, et al.. (1999). Levels of Antibodies to Endotoxin and Cytokine Release in Patients with Severe Trauma. PubMed. 46(5). 907–913. 48 indexed citations
9.
Deckert, P. Markus, Matthias Ballmaier, Stephan Lang, H. Deicher, & I. Schedel. (1996). CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. The Journal of Immunology. 156(2). 826–833. 12 indexed citations
10.
Petry, Karl Ulrich, Ulrike Bode, Heinrich G. Köchel, et al.. (1994). Cellular immunodeficiency enhances the progression of human papillomavirus‐associated cervical lesions. International Journal of Cancer. 57(6). 836–840. 197 indexed citations
11.
Arndt, R., Amber Arnold, E. B. Helm, et al.. (1992). Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Journal of Molecular Medicine. 70(7). 588–94. 65 indexed citations
12.
13.
Wussow, Peter von, D Jakschies, I. Schedel, et al.. (1990). The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS. 4(2). 119–124. 33 indexed citations
14.
Herlyn, Dorothee, et al.. (1989). Modulation of Cancer Patients' Immune Responses by Administration of Anti-Idiotypic Antibodies. Viral Immunology. 2(4). 271–276. 6 indexed citations
15.
Süttmann, U., et al.. (1988). Cytomegalovirus infection in HIV-1-infected individuals. Infection. 16(2). 111–114. 11 indexed citations
16.
Peest, D., Hans‐Joachim Schmoll, I. Schedel, et al.. (1988). VBAMDex chemotherapy in advanced multiple myeloma*. European Journal Of Haematology. 40(3). 245–249. 4 indexed citations
17.
Peest, D., H. Deicher, R. Coldewey, Hans‐Joachim Schmoll, & I. Schedel. (1988). Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMP. European Journal of Cancer and Clinical Oncology. 24(6). 1061–1067. 31 indexed citations
18.
Schedel, I.. (1988). New aspects in the treatment of gram-negative bacteraemia and septic shock. Infection. 16(1). 4–7. 5 indexed citations
19.
Peest, D., et al.. (1986). Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogens.. PubMed. 65(1). 120–7. 10 indexed citations
20.
Schedel, I., Peter Fink, & J. R. Kalden. (1976). Anti-lmmunglobuline bei multiplem Myelom und benigner monoklonaler Hyperglobulin�mie. Annals of Hematology. 32(4). 275–278. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rana Domiati‐Saad Breakdown of academic impact, for papers by A. Graham Bird Breakdown of academic impact, for papers by Lars B. Olding Breakdown of academic impact, for papers by John K. Whisnant Breakdown of academic impact, for papers by T.A. Out Breakdown of academic impact, for papers by D Baume Breakdown of academic impact, for papers by Andreas Morell Breakdown of academic impact, for papers by Bjarte G. Solheim Breakdown of academic impact, for papers by Russell H. Tomar Breakdown of academic impact, for papers by S. S. Crago
Rankless by CCL
2026